Chen YM - Search Results

1

Phase II randomized trial of erlotinib or vinorelbine in chemonaive, advanced, non-small cell lung cancer patients aged 70 years or older.

Chen YM, Tsai CM, Fan WC, Shih JF, Liu SH, Wu CH, Chou TY, Lee YC, Perng RP, Whang-Peng J. Chen YM, et al. J Thorac Oncol. 2012 Feb;7(2):412-8. doi: 10.1097/JTO.0b013e31823a39e8. J Thorac Oncol. 2012. PMID: 22157367 Free article. Clinical Trial.

2

Multiple primary malignancies involving lung cancer-clinical characteristics and prognosis.

Liu YY, Chen YM, Yen SH, Tsai CM, Perng RP. Liu YY, et al. Among authors: chen ym. Lung Cancer. 2002 Feb;35(2):189-94. doi: 10.1016/s0169-5002(01)00408-1. Lung Cancer. 2002. PMID: 11804692

3

Double signal stimulation was required for full recovery of the autologous tumor-killing effect of effusion-associated lymphocytes.

Chen YM, Tsai CM, Whang-Peng J, Perng RP. Chen YM, et al. Chest. 2002 Oct;122(4):1421-7. doi: 10.1378/chest.122.4.1421. Chest. 2002. PMID: 12377874

4

Phase II study of docetaxel and gemcitabine combination chemotherapy in non-small-cell lung cancer patients failing previous chemotherapy.

Chen YM, Perng RP, Lin WC, Wu HW, Tsai CM, Whang-Peng J. Chen YM, et al. Am J Clin Oncol. 2002 Oct;25(5):509-12. doi: 10.1097/00000421-200210000-00017. Am J Clin Oncol. 2002. PMID: 12393994 Clinical Trial.

5

Phase II study of docetaxel and ifosfamide combination chemotherapy in non-small-cell lung cancer patients failing previous chemotherapy with or without paclitaxel.

Chen YM, Shih JF, Lee CS, Chen MC, Lin WC, Tsai CM, Perng RP. Chen YM, et al. Among authors: chen mc. Lung Cancer. 2003 Feb;39(2):209-14. doi: 10.1016/s0169-5002(02)00445-2. Lung Cancer. 2003. PMID: 12581575 Clinical Trial.

6

Intrathecal gemcitabine chemotherapy for non-small cell lung cancer patients with meningeal carcinomatosis--a case report.

Chen YM, Chen MC, Tsai CM, Perng RP. Chen YM, et al. Among authors: chen mc. Lung Cancer. 2003 Apr;40(1):99-101. doi: 10.1016/s0169-5002(02)00504-4. Lung Cancer. 2003. PMID: 12660014

7

A phase II trial of vinorelbine plus gemcitabine in previously untreated inoperable (stage IIIb/IV) non-small-cell lung cancer patients aged 80 or older.

Chen YM, Perng RP, Chen MC, Tsai CM, Ming-Liu J, Whang-Peng J. Chen YM, et al. Among authors: chen mc. Lung Cancer. 2003 May;40(2):221-6. doi: 10.1016/s0169-5002(03)00031-x. Lung Cancer. 2003. PMID: 12711125 Clinical Trial.

8

Phase II study with vinorelbine and cisplatin in advanced non-small cell lung cancer after failure of previous chemotherapy.

Chen YM, Lee CS, Lin WC, Tsai CM, Perng RP. Chen YM, et al. J Chin Med Assoc. 2003 Apr;66(4):241-6. J Chin Med Assoc. 2003. PMID: 12854877 Clinical Trial.

9

Phase II study of gemcitabine and vinorelbine combination chemotherapy in patients with non-small-cell lung cancer not responding to previous chemotherapy.

Chen YM, Perng RP, Lee CS, Lin WC, Tsai CM, Whang-Peng J. Chen YM, et al. Am J Clin Oncol. 2003 Dec;26(6):567-70. doi: 10.1097/01.coc.0000045808.39041.49. Am J Clin Oncol. 2003. PMID: 14663373 Clinical Trial.

10

Impact of severe acute respiratory syndrome on the status of lung cancer chemotherapy patients and a correlation of the signs and symptoms.

Chen YM, Perng RP, Chu H, Tsai CM, Whang-Peng J. Chen YM, et al. Lung Cancer. 2004 Jul;45(1):39-43. doi: 10.1016/j.lungcan.2004.01.002. Lung Cancer. 2004. PMID: 15196733 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,958 results

Search Page

Filters